Medacta Group SA Cash Flow Conversion Efficiency
Medacta Group SA cash flow conversion efficiency. Based on the latest financial reports, Medacta Group SA (MOVE) has a cash flow conversion efficiency ratio of 0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF72.95 Million ≈ $92.23 Million USD) by net assets (CHF424.61 Million ≈ $536.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medacta Group SA (2016–2024)
Cash flow conversion efficiency of Medacta Group SA from 2016 to 2024. This chart illustrates how Medacta Group SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medacta Group SA share price for real-time trading data and today's change.
Medacta Group SA Cash Flow Conversion Ratio Explained
Medacta Group SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medacta Group SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medacta Group SA ranked by their cash flow conversion efficiency. Also see Medacta Group SA market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kiatnakin Phatra Bank Public Company Limited
BK:KKP
|
0.000x |
|
ABM Industries Incorporated
NYSE:ABM
|
0.082x |
|
Applied Opt
NASDAQ:AAOI
|
-0.051x |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
0.002x |
|
China Southern Power Grid Technology Co Ltd
SHG:688248
|
0.024x |
|
Beijing Capital Co Ltd
SHG:600008
|
0.023x |
|
Colbun
SN:COLBUN
|
0.021x |
|
Vietjet Aviation JSC
VN:VJC
|
0.062x |
Annual Cash Flow Conversion Efficiency for Medacta Group SA (2016–2024)
The table below shows the annual cash flow conversion efficiency of Medacta Group SA from 2016 to 2024. Review Medacta Group SA (MOVE) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CHF379.66 Million ≈ $480.00 Million |
CHF107.14 Million ≈ $135.46 Million |
0.282x | +23.97% |
| 2023-12-31 | CHF330.04 Million ≈ $417.26 Million |
CHF75.13 Million ≈ $94.98 Million |
0.228x | -14.95% |
| 2022-12-31 | CHF274.65 Million ≈ $347.24 Million |
CHF73.51 Million ≈ $92.94 Million |
0.268x | +12.08% |
| 2021-12-31 | CHF226.40 Million ≈ $286.23 Million |
CHF54.06 Million ≈ $68.35 Million |
0.239x | -34.00% |
| 2020-12-31 | CHF164.72 Million ≈ $208.25 Million |
CHF59.59 Million ≈ $75.34 Million |
0.362x | +4.57% |
| 2019-12-31 | CHF123.23 Million ≈ $155.80 Million |
CHF42.63 Million ≈ $53.90 Million |
0.346x | -53.60% |
| 2018-12-31 | CHF89.07 Million ≈ $112.61 Million |
CHF66.41 Million ≈ $83.96 Million |
0.746x | +46.94% |
| 2017-12-31 | CHF101.67 Million ≈ $128.54 Million |
CHF51.59 Million ≈ $65.22 Million |
0.507x | +32.33% |
| 2016-12-31 | CHF146.87 Million ≈ $185.69 Million |
CHF56.31 Million ≈ $71.19 Million |
0.383x | -- |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.